Farmaci antiasmatici: metilxantine

Theophylline acts as a bronchodilator through multiple proposed mechanisms. It may inhibit phosphodiesterase enzymes, elevating intracellular cAMP and cGMP levels, which stimulates cardiac function and relaxes airway smooth muscle. Alternatively, theophylline may block adenosine receptors on cell surfaces, increasing adenylyl cyclase activity to promote bronchodilation and reduce inflammation.

Theophylline produces side effects ranging from mild to severe. Mild effects include nausea, vomiting, abdominal discomfort, and headache. More serious adverse effects include seizures and arrhythmias. Due to theophylline's narrow therapeutic window, monitoring blood levels is crucial to prevent toxicity and manage these complications.

Theophylline is typically administered orally as a sustained-release formulation to ensure prolonged therapeutic effect and consistent drug levels. Aminophylline, a combination of theophylline and ethylenediamine, may be administered through slow intravenous injection in specific clinical situations requiring rapid bronchodilation and immediate symptom relief.

Theophylline has been largely replaced by antiasthma drugs inhaled corticosteroids and glucocorticoids and beta-2 agonists, which offer improved efficacy and safety profiles. Due to theophylline's narrow therapeutic window, adverse effects, and toxicity risks, the FDA no longer recommends it for severe asthma exacerbations known as status asthmaticus.

Aminophylline is a combination drug consisting of theophylline and ethylenediamine administered through slow intravenous injection in specific clinical situations where rapid bronchodilation is needed. This formulation allows faster drug delivery and therapeutic onset compared to oral sustained-release theophylline preparations used for routine asthma management.

Theophylline's proposed mechanisms involve elevating intracellular cAMP and cGMP levels through phosphodiesterase inhibition or adenosine receptor blockade. These increased cyclic nucleotide concentrations trigger smooth muscle relaxation in airways, reduce inflammatory responses, and stimulate cardiac function, collectively producing bronchodilation and symptom relief.

Blood level monitoring of theophylline is essential to prevent toxicity and maintain therapeutic efficacy. Due to theophylline's narrow therapeutic window, regular serum concentration checks help clinicians adjust dosing to minimize adverse effects such as nausea, seizures, and arrhythmias while ensuring adequate asthma control and patient safety.